Maprelin 75 microgram/ml solution for injection for pigs

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

Peforelin

Pieejams no:

Veyx-Pharma GmbH

ATĶ kods:

QH01CA

SNN (starptautisko nepatentēto nosaukumu):

Peforelin

Deva:

75 microgram(s)/millilitre

Zāļu forma:

Solution for injection

Receptes veids:

POM: Prescription Only Medicine as defined in relevant national legislation

Ārstniecības grupa:

Pigs

Ārstniecības joma:

Gonadotropin-releasing hormones

Ārstēšanas norādes:

Hormone

Autorizācija statuss:

Authorised

Autorizācija datums:

2009-07-03

Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Maprelin 75 microgram/ml solution for injection for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear, colourless aqueous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (sows and gilts)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For zootechnical use and intended for group or herd treatment.
Induction of the oestrous cycle in sows after weaning
Induction of oestrus in sexually mature gilts following therapy to
inhibit the oestrus cycle with progestagens
4.3 CONTRAINDICATIONS
Do not use in prepubertal gilts, in case of infertility or general
health disorders.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients_._
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
1 ml solution for injection contains:
ACTIVE SUBSTANCE
Peforelin
75.00
µg
EXCIPIENT(S)
Chlorocresol
1.00 mg
For a full list of excipients, see section 6.1.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_0_
_/_
_0_
_8_
_/_
_2_
_0_
_1_
_3_
_C_
_R_
_N_
_ _
_7_
_0_
_1_
_4_
_0_
_4_
_6_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
The product might induce irritation and sensitization.
People with known hypersensitivity to GnRH analogues or any of the
excipients should avoid con